Clinical Trials Directory

Trials / Completed

CompletedNCT04315103

a Single HYAJOINT Plus Combined With a Single PPR Versus a Single PRP for Knee OA

Efficacy of a Single Crosslinked Hyaluronan (HYAJOINT Plus) Combined With a Single Platelet-rich Plasma (PRP) Versus a Single PRP for the Treatment of Knee Osteoarthritis: A Randomized-Controlled Trial

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
85 (actual)
Sponsor
Kaohsiung Veterans General Hospital. · Academic / Other
Sex
All
Age
20 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Intraarticular hyaluronan or platelet-rich plasma (PRP) is each effective in the treatment for knee osteoarthritis (OA). The efficacy of combined hyaluronan with PRP for knee OA remained unclear. This study aimed to investigate the efficacy of a single intraarticular hyaluronan (HYAJOINT Plus) combined with a single PRP versus a single intraarticular PRP in patients with knee OA.

Detailed description

Intraarticular HA or PRP has been used for knee OA for years. Combined HA and PRP has not been widely used for OA because of lack of clinical evidence. Based on in vitro and animal studies, combining HA and PRP may benefit from their dissimilar biological mechanisms for tissue repair and have potentials to synergistically promote cartilage regeneration, inhibit OA inflammation, modulate the disease process, and improve joint homeostasis in OA. Combination of HA and PRP has much potential for the treatment of OA, but the clinical evidence of this combination remains unclear. The purpose of this study was to investigate the efficacy and safety of combined a single crosslinked HA (HYAJOINT Plus) with a single PRP versus a single PRP alone in patients with knee OA.

Conditions

Interventions

TypeNameDescription
COMBINATION_PRODUCTa single intraarticular injection of HYAJOINT Plus (3 ml) followed by 3 ml PRPAll the injections were done by the same experienced physician using aseptic procedures.

Timeline

Start date
2018-08-01
Primary completion
2019-01-10
Completion
2019-07-10
First posted
2020-03-19
Last updated
2020-03-19

Locations

2 sites across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT04315103. Inclusion in this directory is not an endorsement.